SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

ASTRAZENECA PHARMA INDIA

BSE: 506820 29 Sep 2025
Healthcare
₹ 8985
AstraZeneca Pharma India Ltd. specializes in Pharmaceuticals within the Healthcare sector.

ASTRAZENECA PHARMA INDIA - Share Price & Details

Market Cap
₹22,029
High /Low
10,691 / 6,220
Stock P/E
104.0
Book Value
₹308.0
Dividend Yield
0.36
ROCE
33.4
ROE
₹23.6
Face Value
2.0
PEG Ratio
2.41
EVEBITDA
₹63.2
Debt
35.7
CMP / FCF
489.0
Debt to equity
₹0.05
NP Ann
116
High price all time
10,691
Piotroski score
₹6.0
Graham Number
713.0
No. Eq. Shares
2.5
Net CF
₹30.6
Net profit
183
Price to book value
28.6
Interest Coverage
₹139.0
Low price all time
298.0
Industry PE
33.0
Reserves
₹765
Free Cash Flow
₹64.3

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
ASTRAZENECA PHARMA INDIA LTD.5375.5558.35263.122.3322,029104.0
WOCKHARDT LTD.4380.0690.04130.04.2521717426.0
Eris Lifesciences Limited6013.2999.95786.47.332159755.8

Peer Comparison Chart


About ASTRAZENECA PHARMA INDIA

AstraZeneca Pharma India Ltd., with Security Code 506820, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

AstraZeneca Pharma India Pankaj Jain resigns as Legal head

(20 Sep 2025)
Bengaluru: AstraZeneca Pharma India Limited has announced the resignation of Pankaj Jain, Head – Legal.\"We would like to inform that Mr.
Read more →

We Think AstraZeneca Pharma India (NSE:ASTRAZEN) Can Stay On Top Of Its Debt

(16 Aug 2025)
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...
Read more →

AstraZeneca Pharma India’s net profit slips 4 pc in Q1

(15 Aug 2025)
Mumbai, Aug 14 (IANS) AstraZeneca Pharma India Limited on Thursday reported a 4.12 per cent decline in net profit for the first quarter (Q1)...
Read more →

Q1 results today: Ashok Leyland, Vodafone Idea, Indian Oil on Aug 14

(14 Aug 2025)
Ashok Leyland, Indian Oil Corporation Ltd (IOC), AstraZeneca Pharma, Glenmark Pharmaceuticals, Vodafone Idea, and Patanjali Foods are...
Read more →

AstraZeneca to Launch Soliris in India This August

(11 Aug 2025)
Bengaluru, August 6, 2025 — AstraZeneca Pharma India Ltd (NSE: ASTRAZEN / BSE: 506820) has announced that it will launch the Eculizumab...
Read more →

AstraZeneca to Launch Eculizumab in India This August; Shares Down 1.5%

(07 Aug 2025)
Shares of AstraZeneca Pharma India Ltd fell 1.5% on 7th August after touching a day's high of Rs 8,807, despite the company announcing plans...
Read more →